AMITRIPTYLINE AN amitriptyline hydrochloride 10 mg tablets blister pack Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

amitriptyline an amitriptyline hydrochloride 10 mg tablets blister pack

arrotex pharmaceuticals pty ltd - amitriptyline hydrochloride, quantity: 10 mg - tablet - excipient ingredients: lactose monohydrate; microcrystalline cellulose; maize starch; croscarmellose sodium; colloidal anhydrous silica; purified talc; magnesium stearate; macrogol 6000; hypromellose; titanium dioxide; brilliant blue fcf aluminium lake; polyvinyl alcohol; macrogol 3350 - for the treatment of major depression. nocturnal enuresis where organic pathology has been excluded.

AMITRIPTYLINE AC amitriptyline hydrochloride 25 mg tablets bottle Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

amitriptyline ac amitriptyline hydrochloride 25 mg tablets bottle

arrotex pharmaceuticals pty ltd - amitriptyline hydrochloride, quantity: 25 mg - tablet - excipient ingredients: lactose monohydrate; microcrystalline cellulose; maize starch; croscarmellose sodium; colloidal anhydrous silica; purified talc; magnesium stearate; macrogol 6000; hypromellose; titanium dioxide; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - for the treatment of major depression. nocturnal enuresis where organic pathology has been excluded.

AMITRIPTYLINE AC amitriptyline hydrochloride 25 mg tablets blister pack Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

amitriptyline ac amitriptyline hydrochloride 25 mg tablets blister pack

arrotex pharmaceuticals pty ltd - amitriptyline hydrochloride, quantity: 25 mg - tablet - excipient ingredients: lactose monohydrate; microcrystalline cellulose; maize starch; croscarmellose sodium; colloidal anhydrous silica; purified talc; magnesium stearate; macrogol 6000; hypromellose; titanium dioxide; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - for the treatment of major depression. nocturnal enuresis where organic pathology has been excluded.

AMITRIPTYLINE AC amitriptyline hydrochloride 10 mg tablets bottle Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

amitriptyline ac amitriptyline hydrochloride 10 mg tablets bottle

arrotex pharmaceuticals pty ltd - amitriptyline hydrochloride, quantity: 10 mg - tablet - excipient ingredients: lactose monohydrate; microcrystalline cellulose; maize starch; croscarmellose sodium; colloidal anhydrous silica; purified talc; magnesium stearate; macrogol 6000; hypromellose; titanium dioxide; brilliant blue fcf aluminium lake; polyvinyl alcohol; macrogol 3350 - for the treatment of major depression. nocturnal enuresis where organic pathology has been excluded.

AMITRIPTYLINE AC amitriptyline hydrochloride 10 mg tablets blister pack Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

amitriptyline ac amitriptyline hydrochloride 10 mg tablets blister pack

arrotex pharmaceuticals pty ltd - amitriptyline hydrochloride, quantity: 10 mg - tablet - excipient ingredients: lactose monohydrate; microcrystalline cellulose; maize starch; croscarmellose sodium; colloidal anhydrous silica; purified talc; magnesium stearate; macrogol 6000; hypromellose; titanium dioxide; brilliant blue fcf aluminium lake; polyvinyl alcohol; macrogol 3350 - for the treatment of major depression. nocturnal enuresis where organic pathology has been excluded.

RALOVISTA Raloxifene hydrochloride 60 mg tablets, blister pack Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

ralovista raloxifene hydrochloride 60 mg tablets, blister pack

arrotex pharmaceuticals pty ltd - raloxifene hydrochloride, quantity: 60 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; crospovidone; polysorbate 80; povidone; microcrystalline cellulose; magnesium stearate; glycine; titanium dioxide; hypromellose; carnauba wax; macrogol 400 - raloxifene is indicated for the prevention and treatment of osteoporosis in post-menopausal women.,raloxifene is indicated for the reduction in the risk of invasive breast cancer in postmenopausal women with osteoporosis.raloxifene is indicated for the reduction in the risk of invasive breast cancer in postmenopausal women at high risk of invasive breast cancer.

OXYNDONE oxycodone hydrochloride 5mg film coated tablet blister pack Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

oxyndone oxycodone hydrochloride 5mg film coated tablet blister pack

arrotex pharmaceuticals pty ltd - oxycodone hydrochloride, quantity: 5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; sodium starch glycollate type a; magnesium stearate; microcrystalline cellulose; colloidal anhydrous silica; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350; lecithin; brilliant scarlet 4r aluminium lake; indigo carmine aluminium lake - for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

MOXIFLOXACIN APO moxifloxacin (as hydrochloride monohydrate) 400 mg tablet blister pack Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

moxifloxacin apo moxifloxacin (as hydrochloride monohydrate) 400 mg tablet blister pack

arrotex pharmaceuticals pty ltd - moxifloxacin hydrochloride monohydrate, quantity: 436.33 mg (equivalent: moxifloxacin, qty mg) - tablet, film coated - excipient ingredients: lactose; povidone; lactose monohydrate; croscarmellose sodium; colloidal anhydrous silica; magnesium stearate; titanium dioxide; hypromellose; iron oxide red; macrogol 400 - moxifloxacin apo (moxifloxacin hydrochloride) tablets are indicated for the treatment of adults with infections caused by susceptible organisms in the conditions:,- acute bacterial sinusitis,- community acquired pneumonia,- acute exacerbations of chronic bronchitis,appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to moxifloxacin. therapy with moxifloxacin apo may be initiated, in some conditions, before results of these tests are known. once results become available, therapy should be continued with the most appropriate antibiotic therapy.,consideration should be given to available official guidance on the appropriate use of antibacterial agents.

APO-DIMETHYL FUMARATE dimethyl fumarate 240 mg enteric coated capsule blister pack Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

apo-dimethyl fumarate dimethyl fumarate 240 mg enteric coated capsule blister pack

arrotex pharmaceuticals pty ltd - dimethyl fumarate, quantity: 240 mg - capsule, enteric - excipient ingredients: croscarmellose sodium; gelatin; purified talc; magnesium stearate; iron oxide yellow; silicified microcrystalline cellulose; triethyl citrate; titanium dioxide; brilliant blue fcf; methacrylic acid copolymer; colloidal anhydrous silica; iron oxide black; methacrylic acid - ethyl acrylate copolymer (1:1); propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; potassium hydroxide - dimethyl fumarate enteric coated capsules are indicated in patients with relapsing multiple sclerosis to reduce the frequency of relapses and to delay the progression of disability.

APO-DIMETHYL FUMARATE dimethyl fumarate 120 mg enteric coated capsule blister pack Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

apo-dimethyl fumarate dimethyl fumarate 120 mg enteric coated capsule blister pack

arrotex pharmaceuticals pty ltd - dimethyl fumarate, quantity: 120 mg - capsule, enteric - excipient ingredients: croscarmellose sodium; gelatin; purified talc; magnesium stearate; iron oxide yellow; silicified microcrystalline cellulose; triethyl citrate; titanium dioxide; brilliant blue fcf; methacrylic acid copolymer; colloidal anhydrous silica; iron oxide black; methacrylic acid - ethyl acrylate copolymer (1:1); propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; potassium hydroxide - dimethyl fumarate enteric coated capsules are indicated in patients with relapsing multiple sclerosis to reduce the frequency of relapses and to delay the progression of disability.